Louisiana state employee (OGB) GLP-1 plan in 2027: what Act 749 requires
By John Samaras, price analyst. Prices checked Nov 16, 2026.
Act 749 (Senate Bill 250 of 2026) says that from January 1, 2027, Louisiana's Office of Group Benefits (OGB) must offer a voluntary comprehensive weight management plan that includes FDA-approved drugs. A member who joins pays 100% of that plan's premium. OGB told the legislature the date may be too soon to pick a vendor.
What it costs without insurance
If your plan says no
Eden$99 a monthIncludes medication, provider review and shippingCheck price →
Collective$59 a month, drug priceLowest price on our chartCheck price →
Who this affects
Louisiana state employees, retirees and their dependents enrolled in an OGB health plan. Joining the weight management plan is voluntary and is not a condition of any OGB health plan.
When it starts
The law takes effect August 1, 2026 and sets January 1, 2027 for the weight management plan. The Legislative Fiscal Office note of June 1, 2026 records OGB saying that is not enough time to run a request for proposals to pick a vendor, so the start could come later.
If you lose coverage: cash now
Two cash programs to check.
No insurance needed.
Prices checked Nov 16, 2026.
- Eden$99 a monthIncludes medication, provider review and shippingcompounded semaglutidecompounded tirzepatide $129 a monthCheck price →Eden's GLP-1 page, then an online assessment
- Check price →
- Compounded semaglutide and tirzepatide prices, from $59 a month
- Find your GLP-1 program in four questions
What the Act 749 (SB 250, enrolled) says
Beginning January 1, 2027, the Office of Group Benefits shall offer enrollment in a comprehensive weight management plan
- The plan must include FDA-approved drugs, compounded metabolic health therapies, medical evaluations, prescribing oversight, follow-up care and related support.
- The law does not make OGB's health plans change their formulary or medical necessity rules.
- OGB had to tell members by October 1, 2026 how to buy FDA-approved weight-loss drugs direct from the makers.
- A member who buys a weight-loss drug direct from a maker pays 100% of its cost.
- The fiscal note says all premiums for the weight management plan are paid by members, so state agencies pay nothing toward it.
Sources:
- Louisiana Senate Bill 250 (2026 Regular Session), enrolled, dated May 31, 2026, read November 17, 2026.
- Louisiana Legislature, Act 749 resume digest, dated no date printed, read November 17, 2026.
- Louisiana Legislative Fiscal Office, fiscal note on SB 250 (enrolled), dated June 1, 2026, read November 17, 2026.
What to do before January 1
- Watch for OGB's enrollment notice for the weight management plan, and read its premium before you join.
- Compare that premium with buying direct from a maker or the cash routes on this page.
- If you take a GLP-1 for type 2 diabetes, check your OGB health plan's own drug list; Act 749 does not change it.
Louisiana Medicaid and GLP-1s. Employers changing GLP-1 coverage in 2027. Kentucky state employees (KEHP) in 2027.
What cash costs today
Compounded semaglutide and tirzepatide are pharmacy-made versions that are not Wegovy, Ozempic, Zepbound or Mounjaro.
Compounded prices are the monthly drug price at the lowest-priced program. Any membership is listed on that program's own page.
| Cash route | Monthly price | Checked |
|---|---|---|
| Compounded semaglutide | From $59 | November 16, 2026 |
| Compounded tirzepatide | From $69 | November 16, 2026 |
| Wegovy pill from NovoCare | From $149 at the 1.5mg starter dose | November 16, 2026 |
| Zepbound vial from LillyDirect | From $299 at 2.5mg | November 16, 2026 |
Buying cash in late November? GLP-1 Black Friday and Cyber Monday offers shows each program's 30-day low and high.
Frequently asked questions
Will OGB cover GLP-1s for weight loss in 2027?
When does the OGB weight management plan start?
Can OGB members buy GLP-1s direct from the makers?
Cash does not go through your plan and does not count toward its deductible. Federal plan GLP-1 changes for 2027. GLP-1 coverage by payer.